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Mycobacterium leprae is the noncultivable pathogen of leprosy. Since the genome sequence of an isolate ofM.
leprae has become available, multiple-locus variable-number tandem-repeat (VNTR) analysis (MLVA) has
been explored as a tool for strain typing and identification of chains of transmission of leprosy. In order to
discover VNTRs and develop methods transferable to clinical samples, MLVA was applied to a global collection
of M. leprae isolates derived from leprosy patients and propagated in armadillo hosts. PCR amplification,
agarose gel electrophoresis, and sequencing methods were applied to DNA extracts from these infected
armadillo tissues (n  21). We identified polymorphisms in 15 out of 25 short-tandem-repeat (STR) loci
previously selected by in silico analyses of the M. leprae genome. We then developed multiplex PCR for
amplification of these 15 loci in four separate PCRs suitable for fluorescent fragment length analysis and
demonstrated STR profiles highly concordant with those from the sequencing methods. Subsequently, we
extended this method to DNA extracts from human clinical specimens, such as skin biopsy specimens (n 30).
With these techniques, mapping of multiple loci and differentiation of genotypes have been possible using total
DNA extracts from limited amounts of clinical samples at a reduced cost and with less time. These practical
methods are therefore available and applicable to answer focused epidemiological questions and to allow
monitoring of the transmission of M. leprae in different countries where leprosy is endemic.
The causative pathogen of leprosy is Mycobacterium leprae.
A continued incidence, defying global campaigns to eliminate
leprosy even after years of rigorous case finding and the avail-
ability of multidrug therapy regimens (28, 29, 30, 31), is attrib-
uted to subclinical human and environmental reservoirs of the
pathogen (1, 8, 13). In recent years, molecular strain-typing
methodologies have complemented conventional infectious
disease epidemiology. With the publication in 2001 of the
complete genome sequence of an isolate from Tamil Nadu,
India, called the TN strain (4), selection of potential polymor-
phic genomic markers for strain typing was feasible. The first
genetic markers that showed polymorphism were short tandem
repeats (STRs) in the M. leprae genome. One was a 6-bp
intragenic sequence in the rpoT gene, and the second, a trinu-
cleotide (TTC) repeat element upstream of a pseudogene (17,
23). These sequences exhibit variable numbers of tandem re-
peats (VNTRs) when sequenced in different isolates. Based on
these observations, we short-listed 44 loci (including the rpoT
and TTC loci) by in silico analyses of the M. leprae genome and
accomplished the screening of 11 STR loci, of which 9 were
polymorphic when tested in a small panel of four human iso-
lates derived from passage through armadillos (6). Five were
minisatellites (6- to 50-bp repeat units), and four were micro-
satellites (1- to 5-bp repeat units). Since then, others have also
shown that VNTR loci exist in M. leprae isolates (25, 33, 34).
Three single-nucleotide polymorphisms have also been discov-
ered by comparing sequences of a limited number of strains
(20).
The goal of our work has been to discover and apply DNA
variation among M. leprae isolates to identify sources and
chains of transmission of leprosy in regions of endemicity.
There are, however, physiological and practical issues relevant
to strain typing of M. leprae in the clinical setting, such as the
long incubation period and low transmissibility of leprosy and
the requirement for clinical specimens such as slit skin smears
and skin biopsy specimens from leprosy patients due to the
inability of M. leprae to grow in culture. During the course of
the last 4 years, field studies in which STR mapping was im-
plemented have been reported. Matsuoka et al. (16) applied
the microsatellite locus (TTC)21 to type M. leprae strains ob-
tained from nasal swabs and slit skin smears from patients
grouped by village, dwelling, or household in Indonesia, while
Young et al. (33) combined (AT)15, (GTA)9, and (TTC)21
VNTR loci for the identification of short- and long-range M.
leprae transmission chains in areas within and surrounding the
city of Hyderabad, India. Monot et al. mapped five M. leprae
STR loci in patients from Mali, Africa (19). The results from
those studies demonstrated heterogeneity in prevalent hap-
lotypes, indicating that genotype mapping with a small panel
of one to five microsatellite VNTR loci was insufficient to
discern strain relatedness. However, within an intrafamilial
case, three markers were congruent (33). The authors of
those studies concluded that in these areas of endemicity,
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multiple rather than single dominant isolates are found and
that additional genomic markers are necessary for strain
typing.
For these reasons, assays for the amplification and differen-
tiation of multiple genomic loci are needed. When these re-
quirements have been met, it becomes possible to undertake
systematic strain-typing studies that include suitable sampling
strategies and conventional epidemiology methods for moni-
toring transmission and detecting clusters of cases. In light of
these laboratory, field, and clinical issues, we further explored
multiple-locus VNTR analysis (MLVA) techniques. In this
paper, we report the development and testing of multiplex-
PCR methods for MLVA for reference armadillo-derived M.
leprae isolates and clinical materials and address allelic prop-
erties of individual loci and the reproducibility and feasibility
of the techniques. In a future paper, we will apply and extend
these methods to the data from population-based studies in
Cebu, the Philippines (R. M. Sakamuri, M. Kimura, W. Li, K.
Madanahally, H.-C. Kim, H. Lee, M. Balagon, R. Gelber,
W. C. Black, S.-N. Cho, P. J. Brennan, and V. Vissa, submitted
for publication).
MATERIALS AND METHODS
Armadillo-derived human M. leprae isolates. Clinical isolates of M. leprae,
passaged in an armadillo, were obtained from the National Hansen’s Disease
Program (NHDP), Louisiana State University, Baton Rouge, LA, in the form of
infected liver and spleen tissues, as reported in an earlier study (6). Frozen,
infected-armadillo-passaged clinical isolates obtained during the 1970s and 1980s
from the National Institute of Medical Research, Mill Hill, London, United
Kingdom (courtesy of the late Richard Rees and Joseph Colston), and from the
Florida Institute of Technology, Melbourne, FL (courtesy of Eleanor Storrs),
were selected from the remaining inventory of tissues shipped to Colorado State
University (CSU) following the discontinuation of the armadillo colonies at these
institutes.
Clinical samples. A set of 30 skin biopsy specimens from leprosy patients were
selected from previous approved studies. These specimens were from patients
attending the Leonard Wood Memorial Skin Clinic in Cebu, the Philippines,
collected in collaboration with Yonsei University. These biopsy specimens were
frozen immediately upon collection for storage and sectioning.
DNA purification. The Qiagen DNeasy tissue kit (Qiagen, CA) was employed to
obtain total DNA from small portions of infected armadillo tissues (25 to 100 mg).
DNA was eluted in 100 to 200 l elution buffer, and typically 1 to 2 l of DNA was
sufficient for one PCR. Genomic DNA from the Philippines sample collection was
extracted from cryosections at Yonsei University using a previously described
method (32). DNA extracts were provided to CSU. Reference M. leprae NHDP63
DNA was obtained from a large-scale preparation of bacteria from infected liver or
spleen obtained from the NHDP as described previously (6).
VNTR mapping. The methods for STR amplification by PCR using high-
fidelity SuperMix (Invitrogen, CA) and a touch-down thermocycler program
have been described previously (6). The copy numbers (alleles) for all microsat-
ellite loci were determined by direct sequencing of PCR products. Minisatellite
copy numbers were inferred by 3% agarose gel electrophoresis using the EZ
Load 20-bp molecular ruler (Bio-Rad) for product length determination. Se-
quences were obtained for representative products at the Macromolecular Re-
source Facility at CSU and SeqWright (Fisher Biotechnology, Houston, TX).
M. leprae primers for multiplex PCR and fragment length analysis (FLA).
Fluorescent 5-end-labeled forward primers were custom synthesized at Applied
Biosystems, CA (Table 1), and the reverse, desalted primers were custom syn-
thesized at Integrated DNA Technologies, Coralville, IA. These primers were
reconstituted in 1 TE buffer (10 mM Tris-HCl, 1 mM EDTA, pH 8.0) at a 100
M concentration. Aliquots of these master stocks were stored at 20°C. Sep-
arate working stocks of the forward- and reverse-primer sets were prepared
according to the combinations listed in Table 1 and adjusted to a 200-l final
volume with TE buffer, such that each primer was at a concentration of 2 M.
Amplification and detection of STRs using multiplex PCR. Multiplex PCR was
performed using the multiplex-PCR kit (Qiagen). Each reaction mixture (20-l
final volume) was assembled in a PCR cabinet at room temperature and com-
prised 10 l of 2 Qiagen multiplex-PCR master mix, 2 l Q solution, 2 l
(each) of the forward- and reverse-primer working stocks, and 1 to 2 l of
template DNA; the volume was adjusted with PCR-grade water. The final con-
centration of each primer was thus 0.2 M. Following an activation step at 95°C
for 15 min, 40 cycles of PCR were run as follows: denaturation at 94°C for 30 s,
primer annealing at 60°C for 90 s, and primer extension at 72°C for 90 s. The
PCR was terminated with a final extension at 72°C for 10 min. For DNA
TABLE 1. Multiplex STR primers in four different combinations
Multiplex PCR
combination no. Locus
a Forward primerd Tm(°C)e Reverse primer
Tm
(°C)
Amplicon
sizeb (bp)
1 (AC)8b VIC-GCCCACTTACCTCAACCAAC 65.4 CCTATAACGGCACTCAGTCCA 61.4 390
(GTA)9 NED-AGCCTTAGTCGCGCAGATG 62.6 TCCGCTGTCCGTCCGCTGA 68.8 307
(GGT)5 6FAM-GCAGCGGTGTAACAGCATAGC 68.4 TGTCTGCCTTGCGAAACGGTC 65.5 242
(AT)17 PET-TCTCCAACATGCTGCGACA 62.1 GTACAGCGGCCTGATCGAA 60.0 181
6-3ac (rpoT) VIC-ATGCCGAACCGGACCTCGACGTTGA 60.0 TCGTCTTCGAGGTCGTCGAGA 59.5 91
2 21-3 6FAM-GAATCTGACCTTTCGGAAATG 56.8 CGATGCAGCTTCCTACGG 60.7 312
(AC)9 NED-AGCGCCCGTTGTCGATAGA 63.9 GACTGGATGTCGGCACCCC 65.5 236
(AT)15 PET-CAATATGCGGGTTGGCGCTTCTG 66.2 CCGTCTGGCTCGATGGCTGGATTC 68.6 168
(AC)8ac VIC-GTGTTACGCGGAACCAGGCA 65.5 CCATCTGTTGGTACTACTGA 53.5 124
3 27-5 6FAM-ATTGAGCAGATGGCCGGTC 62.8 AGCAGTCGGCACGCCCTT 67.8 327
6-7 VIC-GCCATCGTTGTCGGTTCATC 61.5 CGGAGGAGGTGGGTACGGT 66.1 268
(TA)18 NED-CGTGCGTCGTGTGTAGGC 63.9 GACGTGGCAACATCGAAGTT 61.0 230
(GAA)21 PET-CTACAGGGGGCACTTAGCTC 62.1 GGACCTAAACCATCCCGTTTT 60.4 201
4 18-8 PET-GCCCGTCTATCCGCATCAA 62.5 GCAAAGATCAGCACGCCAAT 61.8 348
12-5 VIC-CTGGTCCACTTGCGGTACGAC 65.1 GGAGAAGGAGGCCGAATACA 61.4 289
23-3 6FAM-CCGAAGCCCTGGACGAAG 63.1 GCCGTAAATCCGCTCCC 56.0 243
(TA)10c PET-TAGATTCAAACGACCATGCA 60.0 TGATAATCACGTGTTTCCGC 60.0 185
a Tandem repeat locus nomenclature per Groathouse et al. (6).
b Amplicon sizes per the sequenced M. leprae TN strain (4).
c Primer sequences per Zhang et al. (34).
d VIC, NED, 6FAM (6-carboxyfluorescein), and PET refer to the 5 fluorochrome.
e Tm, melting temperature.
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sequencing, the multiplex-PCR sample was simply diluted 10-fold; 1 to 2 l was
combined with 10 pmol of the forward primer for the BigDye cycle sequencing
reaction at the Macromolecular Resource Facility at CSU.
FLA. After the multiplex PCR, 1 l of the PCR product was diluted 30- to
60-fold, and 1 l of the diluted PCR product was combined with 12 l deionized
formamide (Applied Biosystems) and 0.3 l of the LIZ-500 DNA standard
(Applied Biosystems). The sample was denatured at 94°C for 5 min and sub-
jected to capillary electrophoresis on the Applied Biosystems genetic analyzer
3130 at the Macromolecular Resource Facility at CSU. The samples were in-
jected into the capillary (50-cm length, POP-7 polymer) by applying an injection
voltage of 1 kV for 22 s. The capillary electrophoresis was run at a voltage of 15
kV at 60°C for 45 min. Following the separation, the electropherograms were
visualized and analyzed using GeneMapper version 3.7 software (Applied Bio-
systems) to determine the major allele for each VNTR locus in each multiplex-
PCR combination.
VNTR data analyses. The microsatellite tool kit (http://animalgenomics.ucd.ie
/sdepark/ms-toolkit/) was used to calculate allele frequency and average allelic
diversity.
RESULTS
Discovery of new VNTRs. In our earlier study (6), 44 loci
suitable for VNTR strain typing were listed. VNTRs were
discovered at seven microsatellite loci containing 1-, 2-, and
3-bp repeat units in a panel of four M. leprae isolates. In the
present study, we screened for polymorphisms within more
microsatellite loci in the same set of isolates (Table 2, taxa 15
to 18). Reliable sequence results for the monomeric G/C-rich
tracts, such as for the (C)20, (G)22, (C)18, and (G)8 loci, were
not obtained even though we were able to obtain PCR prod-
ucts as reported by other groups (25, 34). Previously, we did
not confirm VNTR polymorphism at (AC)9; however, se-
quencing of the products revealed two alleles with eight or nine
copies (6). When we examined the dinucleotide (AC)8b, we
found the seven-copy and not the eight-copy allele, as seen in
the TN isolate and in all four isolates with microsatellite loci.
Of the AT-rich loci, (AT)17, (TA)18, and (AT)15 have already
been proven to be polymorphic (6, 34), so we did not screen
any more AT dinucleotide STR loci at this stage. Four trinu-
cleotide microsatellites [(AGT)5a, (AGT)5b, (ACT)5, and
(GGT)5] were screened; only (GGT)5 was polymorphic, with
two alleles, 4 and 5. All four isolates had three copies of the
pentanucleotide (CACCG) STR, as in the TN strain. From
these screens, (AC)9, (AC)8b, and (GGT)5 have therefore
been included in the panel of microsatellite VNTR loci.
Likewise, we screened the minisatellite 6-3b, 7-3, 10-4, 15-3,
and 23-3 loci for VNTRs within the four standard isolates.
Only the 23-3 locus was polymorphic, showing the two-copy
allele instead of the three-copy allele seen in the TN strain
(Table 2). Similar trends of polymorphisms in STR loci were
detected in an independent study that included Asian isolates
maintained by the system using footpad inoculation of nude
mice (34).
VNTR mapping of an archived collection of M. leprae iso-
lates from various parts of the world. We expanded our ref-
erence panel with a collection of frozen armadillo tissues sent
from the National Institute of Medical Research, Mill Hill,
London, United Kingdom, and the Florida Institute of Tech-
nology, Melbourne, FL. The M. leprae inocula were originally
obtained from leprosy patients from India, Ethiopia, Malawi,
Guyana, the Philippines, and Thailand; such animal infections
were performed during WHO studies to generate sufficient
bacilli for vaccine production (22). M. leprae isolates represent-
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ing the original armadillo infection (from an armadillo infected
with a human biopsy suspension, i.e., passage 0) and isolates
from subsequent armadillo-to-armadillo passages (first, sec-
ond, or third) in these residual tissue banks were tested if
available. We utilized these specimens to assess the purity and
stability of VNTR patterns (Table 2). Tissue records indicated
that in some instances, biopsy homogenates from multiple pa-
tients and/or biopsy specimens were combined for the first
armadillo inoculation. A panel of 16 VNTR loci [10 microsat-
ellites, including (TA)10, and 6 minisatellites] was amplified
and analyzed. All loci with the exception of 6-3a were poly-
morphic, with new alleles being identified within this expanded
collection.
With regard to the purity and stability of VNTR profiles of
M. leprae in these specimens, except in two instances (compare
I480 with A606 and 2936/41 with 3035/299 in Table 2), we
found a characteristic VNTR pattern for 16 loci for each tissue,
despite the possibility that multiple biopsy specimens were
used in the first inoculation. In this VNTR mapping exercise,
we were able to find two isolates (CD236 and I480) that closely
FIG. 1. Gel electrophoresis and FLA of 15 VNTR loci from five Cebu, the Philippines, clinical isolates amplified using the combination 1, 2,
3, and 4 primer sets. (Aa, Ba, Ca, and Da) Gel electrophoresis of multiplex-PCR products (combinations 1 to 4). Lanes: M, 20-bp DNA marker
(Bio-Rad); P, multiplex-PCR products from NHDP63 (positive control); 28, 32, 35, 39, and 42, multiplex-PCR products from clinical isolates; N,
negative control. (Ab, Bb, Cb, and Db) Electropherograms obtained from FLA, where the orange peaks represent the LIZ-500 size standards and
red, blue, black, and green peaks represent the VNTR products in each of the combinations. Arrows indicate the peaks selected as the allele for
each locus.
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matched the profile of the original sequenced TN isolate (4).
The combined presence of the TN-like 23-3 locus and 21 cop-
ies of the TTC triplet is a signature not found in any of the
other isolates. In this collection of 21 armadillo-derived M.
leprae isolates and the in silico data from the TN genome, the
number of haplotypes was 16, with a genetic diversity of 0.5463,
which is a measure of diversity across the 15 VNTR loci (Table
2), and was calculated in the microsatellite tool kit that uses
Nei’s definition of gene diversity (21).
Selection of VNTR loci and primer combinations for multi-
plex PCR. We then developed a multiplex-PCR approach for
strain typing of clinical isolates. We utilized primer sequences
described by us or others in various combinations to enable
simultaneous amplification of three or four loci, such that the
products were detectable in the 3% agarose gel, with minimum
overlap (Fig. 1). The combinations listed in Table 1 proved to
be satisfactory. At present, there are four combinations for
amplification of 15 loci. Primer sets for loci 6-3a and (TA)10
have been subsequently added to combinations 1 and 4, re-
spectively, allowing mapping at 17 STR loci.
Multiplex PCR and FLA for clinical samples. All the com-
binations were optimized with NHDP63 DNA obtained from
FIG. 1—Continued.
VOL. 47, 2009 STRAIN TYPING OF M. LEPRAE 1761
the tissue of an armadillo infected with the isolate from a
leprosy patient and subsequently utilized as our reference
DNA for VNTR mapping (6). In order to test the feasibility of
multiplex PCR and FLA for clinical samples, we used DNA
from 30 stored biopsy samples from leprosy patients (Fig. 1Aa,
Ba, Ca, and Da). The VNTR alleles for NHDP63 and the 30
clinical isolates are shown in Table 3.
The addition of Q solution, a cosolvent that can alleviate
amplification problems associated with secondary structure
and/or high GC content, was found to be useful for some loci
and was therefore routinely included in the PCR mixture. In
addition to being subjected to conventional agarose gel elec-
trophoresis, the products of the multiplex PCRs were sub-
jected to FLA (Fig.1Ab, Bb, Cb, and Db).
We also retested several of the armadillo-derived M. leprae
isolates (Table 2) by this multiplex-PCR–FLA method and
obtained concordant alleles. Interestingly, the FLA profile
from the tissue infected with strain 3035/299 from Malawi,
which was previously thought to be different from 2936/41
(0-passage specimen) at multiple loci, was found to carry two
alleles at these loci, one the same as that found in 2936/41,
along with secondary alleles. The results were reproduced
when a different scraping from the same frozen tissue was used
for DNA extraction and typing.
Stutter phenomena and 3 base tailing and allele deter-
mination. Stutter products, defined as products formed by
slipped-strand DNA synthesis at repeat regions, were com-
monly observed for the microsatellite loci. We observed both
minus and plus stutters ranging from 3 to 3 repeats with
reference and clinical template DNAs (Table 4). The addition
of an extra base at the 3 end of PCR products (nontemplate
3 extension) was also observed. The extent and pattern of
stutters and 3 tailing tended to be characteristic for each locus.
Despite the stutter and 3 base tailing, we were able to select
the peaks, as indicated by the arrows in the electropherograms
of Fig.1 Ab, Bb, Cb, and Db for the reportable alleles of the
majority of the loci. A nonspecific product peak at 242 bp
(NED label, black peak) in combination 3 can be seen with
human-derived specimens.
Concordance between VNTR alleles determined by fragment
length analysis and DNA sequencing. In order to verify the
FLA-based allele calls, a subset of samples was submitted to
multiplex PCR using unlabeled primers and DNA sequencing
of amplicons. For each combination, we randomly tested at
TABLE 3. VNTR data from clinical samples using FLA from Cebu, the Philippines
Strain or taxon
No. of copies found at the indicated locus with multiplex-PCR combination:
1 2 3 4
(AC)8b (GTA)9 (GGT)5 (AT)17 21-3 (AC)9 (AT)15 (AC)8a 27-5 6-7 (TA)18 (TTC)21 18-8 12-5 23-3
NHDP63 7 10 4 13 2 8 16 10 4 7 16 10 8 5 2
13 8 9 5 18 3 9 15 9 5 7 26 31 8 5 2
14 8 11 5 15 3 9 16 9 5 7 18 24 8 4 2
15 8a 11a 5a 12a 3 8 17 9 5 7a 18a 22a 8a 4a 2a
16 8 9 5 14 3 10 13 9 5 7 21 19 8 5 2
17 7 10 4 13 1a 9a 13a 9a 5a 8 15 14 7 4 2
18 8a 10a 5a 14a 3 8 16 9 5 7 20 36 8 4a 2a
19 7 8a 4 14 1a 9a 17a 9a 5a 8a 14a 16a 7a 4a 2a
20 8a 9a 5a 16a 3a 9a 12a 8a 5a 8a 18a 23a 8a 4a 2a
21 6 11 5 12 3a 8a 19a 9a 5a 7 25 29 8 4a 2a
22 6a 11a 5a 12a 2a 9a 13a 11a 5a 6a 13a 20a 8a 4a 2a
23 8 9 5 16 3 8 11 9 5 8 17 28 8 4 2
24 8 9 5 17 3 9 14 9 5 7 16 22a 8 5 3
25 7 10 4 14 1 8 15 9 5 8 15 20 7 4 2
26 8 8a 5 18 3 9 13 10 5 7 18 19a 8 5 3
27 8 8 5 16 3 10 15 9 5a 7a 18a 31a 8 5 2
28c 7 9 6 19 3 9 20 10 5 6 22 25 8 4 2
29 7 9 6 16 3b 9b 19b 10b 5b 6b 20b 24b 8 4 2
30 7 11 5 13 3b 8b 15b 8b 5b 7b 23b 24b 8 4 2
31 NDd 11 ND 17 3 ND 15 9 4 ND 23 28 ND 5 2
32c 8 9 5 16 3 10 21 9 5 7 16 23 8 5 2
33 7b 9b 4b 13b 1b 9b 14b 9b 5b 8b 13b 16b 7b 4b 2b
34 8 9 5 15 3b 9b 15b 9b 5b 7b 21b 27b 8 5 2
35c 8 9 5 15 3 9 14 9 5 7 21 26 8 5 2
36 8 10 5 15 3b 9b 21b 9b 5b 6b 20b 26b 8 5 2
37 8 9 5 15 3b 9b 15b 10b 5b 7b 18b 24b 8 5 2
38c 8 9 ND 16 3 9 15 9 5 7 17 27 8 5 2
39c 8 12 5 14 3 10 17 9 5 7 26 23 8 4 2
40 ND ND ND 15 1b 9b 14b 9b 4b 4b 15b 25b 8 5b 2b
41 8 10 5 18 3b 9b 14b 9b 5b 8b 21b 31b 8 5 2
42c 8 13 5 12 3 9 19 10 5 7 16 24 8 4 2
a Also sequenced.
b Two FLA runs using the same PCR sample were carried out.
c Three PCRs and three FLA runs (two PCRs with a Qiagen multiplex-PCR kit and one with an ABI AmpliTaq Gold PCR master kit) were performed.
d ND, not detected.
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least three DNA isolates. The alleles determined by sequenc-
ing of the amplicons were in concordance with those estimated
by the FLA (Table 3).
Reproducibility of multiplex PCR and FLA. In order to test
for the run-to-run reproducibility of the multiplex PCR and
FLA, multiplex PCR was performed several times using
NHDP63 DNA and the products from each PCR were sub-
mitted to FLA on separate days. Overall, the peak sizes and
patterns remained stable between independent PCRs and FLA
experiments. The average amplicon sizes and standard devia-
tions for each locus determined from 10 such experiments are
shown in Table 4. The multiplex-PCR and FLA reproducibility
was also verified for clinical isolates. Samples 28, 32, 35, 39,
and 42 were subjected to multiplex PCR and FLA at least
three times, twice with Qiagen multiplex enzyme and once with
a high-fidelity enzyme (AmpliTaq Gold; Applied Biosystems).
Concordant FLA peaks were observed from all three runs,
which also demonstrated that the variation due to the DNA
polymerase is minimal. Furthermore, when stored multiplex-
PCR products were rerun for FLA, there were no significant
changes in the profiles, indicating that products can be stored
(up to a year at 20°C) and analyzed at a subsequent conve-
nient time and location.
DISCUSSION
The goal of our studies is to generate useful molecular
epidemiological tools for monitoring the residual leprosy bur-
den in countries of endemicity to complement local surveil-
lance and control programs. Prolonged contact with a leprosy
patient is a known risk factor, but only 10 to 30% of the new
cases can be linked to an index case (2, 26). The number of new
cases among children is not insignificant (a sign of recent
transmission). Isolates resistant to one or more antileprosy
drugs are being detected in different countries of endemicity,
and the relapse rates among treated cases are 13% (5, 7, 9,
14). In addition, the concept of zoonotic transmission has not
been excluded (18). Thus, finding a source(s) and chains of
transmission by strain typing is a practical application. Special
considerations for the molecular epidemiology of leprosy in-
clude the long doubling time of M. leprae, followed by an
incubation period of 2 to 8 years before symptoms may be
perceived or diagnosed and the lack of laboratory cultivation
methods for M. leprae.
Furthermore, outbreaks are not common, though intrafamil-
ial clusters exist and pockets of hyperendemicity have been
reported (11, 12).
In this context, we pursued our strategy to identify polymor-
phic markers for M. leprae for strain-typing applications (6). Of
the common methods for infectious pathogens, we and others
have explored STR analyses for leprosy transmission, because
nucleotide substitutions, inversions, recombinations, and trans-
positions had been found to be rare (3, 27). The preferred
method for measuring evolutionary distance between two sam-
ples takes into account the allele sizes (number of repeating
units) at each VNTR locus. During the course of our experi-
ments, three novel single-nucleotide polymorphisms which led
to a model for the origin and global spread of leprosy were
discovered (20).
In light of field studies indicating that one to three micro-
satellites were insufficient for the detection of strain diversity
and the transmission of M. leprae, we exploited the availability
of a laboratory collection of 21 human clinical specimens pas-
saged in armadillos for the purpose of identifying new genomic
loci. Independently, a study performed with a different sample
set composed of 27 mouse-derived human isolates, primarily
from Japan but also including one isolate each from the Re-
TABLE 4. Amplicon sizes, 3 tailing effect, and stutter products detected by FLA for NHDP63e
Multiplex-PCR
combination Locus Amplicon size
d 3 tailing
effect
Presence or absence of stutter products:
3 2 1 1 2 3
1 (AC)8b 384.15  0.1589 b      
(GTA)9 307.86  0.4416 b      
(GGT)5 238.53  0.3047 b      
(AT)17 174.83  0.0961       
2 21-3 289.75  0.3965 b      
(AC)9 231.58  0.2792 a      
(AT)15 173.54  0.2251 b      
(AC)8a 125.17  0.1555 b      
3 27-5 300.61  0.1253 b      
6-7 263.95  0.2714 a      
(TA)18 224.51  0.1618       
(GAA)21 169.80  0.1354      
4 18-8 346.20  0.2149  c c c   
12-5 286.96  0.2742 b      
23-3 219.40  0.2408 b      
a 3-end tailed and blunt PCR products are detected in approximately equal proportions.
b 3 tailing proceeds to near completion; the blunt PCR product is limited in abundance.
c Position1,2, and3 stutter products are weak. Instead, peaks at the two-copy and three-copy allele positions can be seen, which would be the5 and6 stutter
products for NHDP63.
d Average amplicon size  standard deviation from 10 independent multiplex-PCR and FLA experiments. FLA was performed on the ABI Genetic analyzer 3130.
e  and  signs indicate the presence and absence, respectively, of 3 tailing or stutter products.
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public of Korea and Indonesia and three isolates from Thai-
land, showed that the list of polymorphic loci are equivalent to
that from our study. Locus 10-4 is comprised of four 10-base
repeats, with a consensus repeat sequence: ttATTAATAA (6).
The lowercase “tt” in the minisatellite 10-4 represents noncon-
served bases within the tandem repeat unit sequence. The
repeat units 1, 2, and 4 have TT, while repeat unit 3 has CG.
Polymorphisms were not found either in the copy number or in
the nonconserved nucleotides present at the first and/or second
position in any of the repeats, even though locus 10-4 is situ-
ated in a noncoding region. The 7-3 locus is contained within
a putative functional open reading frame in which VNTRs
would cause frameshifting, perhaps the reason that the 7-3
locus was not polymorphic. The 23-3 locus was peculiar be-
cause the TN pattern with three copies was rare. We discov-
ered a 5-base deletion in the third repeat in two isolates from
Ethiopia. We have termed this allele 23-3. Zhang et al.,
showed that 32 of the 44 loci in our first list are polymorphic;
of these, they selected 9 loci (all microsatellites) for determin-
ing strain identity in isolates collected from families with mul-
tiple cases (34).
To improve throughput, we have developed a multiplex-
PCR approach suitable for rapid amplification of 15 VNTR
loci from M. leprae-containing specimens like slit skin smears
and skin biopsy specimens. The benefits are reduced PCR
reagent consumption, including of the DNA template, and
ease of setup. Of these 15 VNTR loci, 6 are minisatellites and
9 are microsatellites. Two more loci [6-3a and (TA)10] have
since been included in the PCR. Microsatellites tend to exhibit
higher allelic diversity than minisatellites, even in localized
collections, and when combined with minisatellites are useful
in differentiating specimens from different countries/geograph-
ical regions (Table 5). For the 21 armadillo samples plus that
of strain TN, a gene diversity of 0.5463 was observed for 16
loci. A similar trend was seen for the 30 clinical isolates from
the Philippines (gene diversity of 0.54 for 15 loci). For the
same loci, the gene diversity of the 27 isolates (mainly of
Japanese origin) reported by Zhang et al. (34) is 0.6. These
diversity indices are comparable to those in other bacterial
VNTR-based typing systems. With Bacillus anthracis, an eight-
VNTR-locus system was used for strain typing. An average
diversity of 0.52 for 89 isolates was shown (10). With Salmo-
nella enterica serotype Enteritidis, Malorny et al. demonstrated
a typing system based on nine VNTR loci (with individual
allelic diversity ranging from 0.07 to 0.65) which allowed fur-
ther discrimination of isolates within single phage types (15).
The average diversity was 0.42 for this collection of 240 iso-
lates. In the context of the strain typing of Mycobacterium
tuberculosis, different genomic markers and combinations have
been utilized. The locus diversity varied from 0.1 to 0.8 when
24 mycobacterial interspersed repetitive unit VNTR loci were
applied to a set of 90 isolates from a standardized worldwide
collection. These loci have been recommended for high-reso-
lution phylogenetic studies (24). This data set represents an
average genetic diversity of 0.58 for the 24 loci.
In addition, we developed the FLA method for mapping
VNTR alleles, which is more rapid than the conventional se-
quencing method. To validate and standardize the technique,
reference strain NHDP63 was used (Table 4) and included
every time clinical samples were analyzed. Although the mini-
satellite banding profiles can easily be interpreted by visual
inspection after electrophoresis on conventional agarose gels,
it was convenient to include these in the multiplex-PCR com-
binations for FLA. Rapid mapping of 15 VNTRs in a set of 30
clinical specimens obtained from one clinic has been demon-
strated using the multiplex-PCR–FLA technique. The ampli-
con sizes were found to be reproducible from run to run for the
reference stain and the clinical isolates. However, the sizes (in
bp) do not correspond to the calculated size of the DNA
fragments (Table 4). This could be due to the nature of the gel
matrix, differences during migration between labeled PCR
fragments, capillary length, the ladder used for calibration, the
sequence composition, and the models of Applied Biosystems
genetic analyzers. So we recommend that a reference strain
(such as NHDP63 in our experiments) be used in all of the runs
for consistency in allele definitions for a given instrument
within a laboratory. The allelic diversity for M. leprae in the
Philippine sample collection is shown in Table 5.
For the minisatellite 18-8, minus stutter peaks were ob-
served. These appear at copy positions 2 and 3. Even though
some of the microsatellites are prone to the stutter phenome-
non (in vitro and in vivo) and 3 tailing effect, electrophero-
grams can be interpreted to assign alleles. The removal of the
3 tail artifacts by a high-fidelity enzyme minimized the com-
plexity of the peaks, as was seen for the (AT)15 products (not
shown). Stutter products are also often observed in conven-
tional sequence traces, wherein the stutter product sequences
merge, making it difficult to read the sequence at the end of
the repeat region. However, in FLA, the main product and the
stutter products are clearly discernible. This suggests that the
FLA technique is more convenient for detecting such products
and reporting the predominant alleles than conventional se-
quencing. Strain typing allows us also to compare and confirm
the identities of laboratory reference strains. For example, the
VNTR pattern of the Thai-53 isolate in our study is quite
different from that described by Zhang et al. (34) but is
probably the same as that discussed by Monot et al. (20).
The original strain was isolated in Japan from a Thai patient
(25, 34).
VNTR stability throughout two passages in armadillo was
noted in our studies, except with two M. leprae suspensions.
With the information available to us for the archived tissues,
we surmise that 2936/41 and 3035/299 originated from one
common original inoculation in 1983. Tissue or animal 2936/41
represents passage 0 (patient to armadillo), while 3035/299 is
that of passage 2 (armadillo to armadillo) (date not known).
Unfortunately, the intermediate “passage 1 tissue” was not in
our collection when we started this study. Therefore, we are
unable to test or demonstrate when or how an additional
VNTR profile emerged in the passage 2 isolate. We can pro-
pose only that the alternate alleles in 3035/299 represent a
secondary strain rather than that they arise from VNTR insta-
bility sometime during incubation or passage because 11 of 16
loci carried two alleles. Endogenous infection of the host ar-
madillos is another possibility. Similarly, regarding samples
I480, I478, and A606, we inferred that they were derived from
the same human inoculum. The passage 0 animal was also
common for all three. I480 and I478 are from “passage 1”
infections but in two different animals. These tissue specimens
gave matching M. leprae VNTR patterns. A606, which is a
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passage 2 tissue, did not originate directly from either I480 or
I478 but from a different animal. The tissues corresponding to
passage 0 and the precursor to A606 were not present in our
sample bank for this study, so we cannot speculate on the
origins of the different M. leprae genotypes seen in A606 (al-
leles at 11 of 16 loci were altered) compared to I480 and I478.
For those armadillos infected with approximately three patient
biopsy homogenates, it appears that one isolate was dominant
in the first two passages. Truman et al. demonstrated that
microsatellites were highly stable after multiple passages in
armadillo and/or nude mice, albeit allele shifts by one or more
repeat units were not infrequent (25). Matsuoka et al. demon-
strated that the TTC (GAA) locus was stable after 11 passages
in nude mice (16).
This study was undertaken mainly for developing methods
for VNTR-based strain typing. There was limited epidemio-
logical or clinical information associated with the 30 coded
clinical frozen samples (Table 3). However, it was possible to
identify four isolates (17, 19, 25, and 33) which have alleles 4
and 1 for the loci (GGT)5 and 21-3, respectively. These isolates
cluster and separate when analyzed by the neighbor-joining
method (data not shown). For the same loci, the alleles are 6
and 3 for the pair of isolates (28 and 29) which also cluster but
into a different branch. There was no association with genotype
and village or city. In a larger study which included these 30
samples and 170 more that were collected from patients in the
same province since 2003, a well-defined population structure
with distinct VNTR signatures was identified. Several pairs
TABLE 5. Allele diversity detected for M. leprae STR loci in leprosy patients from the Philippines
Diversity at indicated STR locus
Allele Frequency Allele Frequency Allele Frequency
(AC)8a (AC)8b (AC)9
8 6.90 6 7.14 8 20.69
9 72.41 7 25.00 9 65.52
10 17.24 8 67.86 10 13.79
11 3.45
(AT)15 (AT)17 (TA)18
11 3.45 12 13.79 13 3.45
12 3.45 13 13.79 14 6.90
13 13.79 14 17.24 15 6.90
14 3.45 15 20.69 16 6.90
15 24.14 16 20.69 17 13.79
16 20.69 17 3.45 18 17.24
17 6.90 18 10.34 19 3.45
18 3.45 20 3.45
19 6.90 21 13.79
20 6.90 22 10.34
22 6.90 25 3.45
26 10.34
(GGT)5 (GTA)9 (GAA)21
4 15.38 8 10.71 14 3.45
5 80.77 9 46.43 16 6.90
6 3.85 10 17.86 19 6.90
11 17.86 20 6.90
12 3.57 22 13.79
13 3.57 23 13.79
24 13.79
25 6.90
26 6.90
28 3.45
29 3.45
30 3.45
31 6.90
36 3.45
6-7 12-5 18-8
4 3.45 4 55.17 7 14.29
6 13.79 5 44.83 8 85.71
7 58.62
8 24.14
21-3 23-3 27-5
1 17.24 2 93.10 4 3.45
2 3.45 3 6.90 5 96.55
3 75.86
4 3.45
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of isolates with matching genotypes associated with multi-
case families or communities could be noted (Sakamuri et
al., submitted).
Our future work is focused on improving the sensitivity of,
detecting mixed VNTR patterns in, automating allele calling
in, and eliminating nonspecific peaks (usually seen in samples
with low bacterial numbers) in multiplex PCR and FLA. We
have initiated the generation of databases that include all avail-
able polymorphism data along with relevant clinical informa-
tion for each sample so as to enable molecular geneticists and
clinical epidemiologists objective means for tracing leprosy and
for implementing preventive measures. These approaches will
be explored in a future paper (Sakamuri et al., submitted).
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